Shelter Cannabis

MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) has executed a supplementary agreement to its asset purchase agreement with 1193269 B.C. Ltd., operating as Shelter Cannabis for the Shelter Cannabis Brands IP portfolio, ending any ongoing royalty payments after August 31, 2023. Under the...

MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE:MLZ) revenue decreased 11.24% to $4.88 million in Q1 2022 compared to $5.5 million in Q1 2021. Q1 Financial Highlights Gross profit was a loss of $403,000 compared to a loss of $680,000 in 2021 Net loss was $7.46 million, compared to a net...

MediPharm Labs Corp. (OTCQX: MEDIF) (TSXV:LABS) (FSE:MLZ) has acquired the intellectual property portfolio of Shelter Cannabis, including cannabis dried flower and pre-roll products, manufacturing know-how, trademarks, marketing assets and provincial listings. MediPharm will pay Shelter based on an...